For how we live.
The first dedicated Global Burden of Disease analysis of passive smoking finds exposure falling in relative terms but stuck in absolute numbers, and still causing 1.66 million deaths a year — most from heart disease.
A new history of Norway's 1975 ban — one of the WHO's three 'best buys' against alcohol harm — traces how it survived courts, alcohol-free beer and social media, and why pressure to modernise it worries defenders.
The first GBD 2023 estimate of heart failure maps not just its size but its causes — and the causes split the world: alcohol in eastern Europe, Chagas disease in Latin America, rheumatic disease in the global south.
A GBD 2023 analysis counts the global health workforce by sex for the first time, and finds it nearly tripled since 1990 — yet still falls tens of millions of workers short of universal health coverage.
Task-sharing therapy to lay community workers is the backbone of WHO's plan for closing the treatment gap. A synthesis of 28 studies asks what the model costs the workers themselves.
In deficient populations, vitamin A supplements cut child deaths by 12% — among the best-evidenced global-health interventions. In the well-nourished, added vitamin A does no good and can do harm.
Most newborn jaundice needs no treatment. The reason clinicians watch it is a rare progression to brain injury — a burden that falls overwhelmingly on poorer countries.
Two large African trials gave anaemic pregnant women intravenous ferric carboxymaltose or oral iron. Neither found less anaemia near term, or heavier babies, with the infusion.
The E-MOTIVE trial, across 80 hospitals and 210,132 births in four African countries, paired objective blood measurement with a first-response bundle — and severe outcomes fell sharply.
In a prospective African validation, TB-detection AI matched radiologists but neither hit the WHO sensitivity target. In an Indian field programme, AI-led screening lifted case-finding sharply.
Gavi is funding a standing mpox vaccine stockpile, coordinated by the same group that manages emergency supplies for cholera, yellow fever and Ebola, to avoid repeating the 2022 access gap.
A meta-analysis of more than 155,000 children finds mortality is elevated even at oxygen saturations of 90–94%, above the threshold at which WHO advises hospital oxygen.
An analysis of global temperature data from 1950 to 2024 finds the share of the world's population facing dangerous heat-stress days has climbed sharply since the 1970s, summarized this month in JAMA.
The UK and Rwanda reported the highest anxiety, depression, and vasomotor symptom scores; Nepal, Sri Lanka, Malaysia, and Singapore reported the lowest. Burnout emerged as the symptom most connected to everything else.
In a 122-patient South African proof-of-concept study, a four-month all-oral combination of quabodepistat, delamanid and bedaquiline cleared TB from sputum as often as the six-month standard.
Intimate partner violence has declined by 0.2% a year over two decades. The report also produces the first national and regional estimates of sexual violence by someone other than a partner.
WHO's Global Tuberculosis Report 2025 counts 10.7 million people ill and over 1.2 million dead last year. Available funding is US$5.9 billion against a US$22 billion annual target.
VENUSCANCER assembled individual records for 275,792 women from 103 cancer registries in 39 countries. The gaps it found are in what treatment women actually received, not only in whether they were diagnosed.
The 2024 amendments to the International Health Regulations took effect in September 2025, adding a 'pandemic emergency' tier. The United States formally rejected them.